Teplizumab Drug Approved for NHS to Delay Type 1 Diabetes Onset

The NHS has initiated the rollout of Teplizumab, the first drug approved to delay the onset of type 1 diabetes, representing a significant milestone in diabetes treatment. This therapy could postpone the onset of the disease by up to three years, thereby possibly improving the quality of life for at-risk patients.